What are Antisense oligonucleotides?

Update: 2019-09-04

Description

In this episode Dr. Steve Perrin, CEO at the ALS Therapy Development Institute and Dr. Fernando Vieira, CSO at ALS TDI join us to talk about Antisense Oligonucleotides (ASOs). ASOs are molecules, mostly DNA, that are specifically designed to target and suppress the expression of a specific gene. They work by binding directly to messenger RNA (mRNA) and block it from producing a specific protein.

Access all episodes of the Endpoints Podcast.

Support the show.

Comments

In Channel

Lou Gehrig Day: Celebrating a Legend and Raising ALS Awareness

2021-05-1422:11

Braingate: Helping People with ALS Control Devices with their Minds

2021-02-2627:31

The Lloyd Brothers: Racing for ALS

2020-02-0719:46

What to Know About CMAP

2020-01-2716:30

What to know about AMX0035

2019-10-3108:34

Collin Hadley: Choosing to use Mechanical Ventilation for ALS

2019-10-1621:28

Samantha Van Saun: Building an ALS Community

2019-10-1506:46

NurOwn and the Hope for Stem Cells in ALS?

2019-10-1512:41

Tamara Hillard: Anticipating Needs as an ALS Caregiver

2019-10-1507:26

Jeff Roosa: Uniting First Responders to End ALS

2019-09-1820:14

What to know about CuATSM clinical trials

2019-09-1810:41

What Do We Know About C9ORF72?

2019-09-1812:02

Andy McGovern: Living with MND Against the Odds

2019-09-1709:58